Clinical Trial

Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A

Name: Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A — clinical trial record (NCT03766763)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Open label, single arm, multicenter phase II trial.

Protocol Amendment History 9 amendments

This ClinicalTrials.gov record has been amended 9 times since 2018-12-05; most recent amendment 2025-11-21.

Status change: Recruiting → Active, Not Recruiting 2024-10-25

Status change: Not Yet Recruiting → Recruiting 2019-06-19

Trial Details

NCT Number	NCT03766763
Lead Sponsor	French Innovative Leukemia Organisation
Conditions	Chronic Lymphoid Leukemia
Enrollment	82 participants
Start Date	2019-05-22
Primary Completion	2022-01-01 (estimated)
Study Completion	2030-04-24 (estimated)
Updated on ClinicalTrials.gov	2025-11-26